Interesting philby. If I'm reading you right - So many thinking about, some even worrying about a takeover, but with Fuji and Cellularity positioned as major shareholders taking advantage of the very considerable number of CYP00x licensing opportunities, AND consequently driving the price up through licensing announcements and PR, Cynata could simply end up as a holding company with potential for the sp to move to $40, $50 and beyond. Competitive tensions ebb away and Fuji and Cellularity reap the benefits in two ways. Puts a different and far more exciting perspective on things for sure!
Add to My Watchlist
What is My Watchlist?
